| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 16, 2025 | Oncology Institute, Inc. | Director | Sell | 22.5 | -13,333 | -1.91% | ✗ | $50.3K |
| Aug 19, 2025 | Aug 21, 2025 | Oncology Institute, Inc. | Director | Sell | 22.5 | -20,221 | -3.14% | ✗ | $82.1K |
| Jun 3, 2025 | Jun 5, 2025 | Oncology Institute, Inc. | Director | Sell | 16.3 | -1,976,137 | -76.61% | ✗ | $5.7M |
| Mar 26, 2025 | Apr 28, 2025 | Oncology Institute, Inc. | Director | Buy | 86.3 | +45,280 | 6.79% | ✗ | $47.2K |
| Mar 26, 2025 | Mar 28, 2025 | Oncology Institute, Inc. | Director | Buy | 77.5 | +9,056 | 1.36% | ✗ | $9.4K |
| Nov 12, 2024 | Dec 2, 2024 | Oncology Institute, Inc. | Director | Buy | 22.5 | -53,450 | -7.42% | ✗ | $50K |
| Jun 17, 2024 | Jun 20, 2024 | Oncology Institute, Inc. | Director | Sell | 47.5 | -18,121 | -2.61% | ✗ | $8.3K |
| May 22, 2024 | May 23, 2024 | Oncology Institute, Inc. | Director | Sell | 46.3 | -19,526 | -2.74% | ✗ | $11.2K |
| Nov 21, 2023 | Nov 22, 2023 | Oncology Institute, Inc. | Director | Sell | 22.5 | -25,867 | -3.71% | ✗ | $56.7K |
| Nov 17, 2023 | Nov 21, 2023 | Oncology Institute, Inc. | Director | Sell | 22.5 | -25,000 | -3.46% | ✗ | $56K |
| Nov 13, 2023 | Nov 15, 2023 | Oncology Institute, Inc. | Director | Sell | 22.5 | -74,117 | -9.61% | ✗ | $183.3K |
| Nov 15, 2022 | Nov 22, 2022 | Oncology Institute, Inc. | CEO | Sell | 46.3 | -9,718 | -2.10% | ✗ | $19.7K |
| Nov 15, 2022 | Nov 17, 2022 | Oncology Institute, Inc. | CEO | Sell | 46.3 | -9,718 | -2.10% | ✗ | $19.7K |